Eric Rothe
Director at Greenwich LifeSciences, Inc. (GLSI)
Eric Rothe has filed 2 insider reports with the SEC since June 2022, as director at Greenwich LifeSciences, Inc. (GLSI). The latest filing, on December 27, 2024, reports grant or award at Greenwich LifeSciences, Inc. (GLSI).
- Filings
- 2
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Eric Rothe is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | $19.25 | Dec 27, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Dec 24, 2024GLSISEC Form 4 filed by Director Rothe EricForm 4Grant or award
- Jun 22, 2022GLSISEC Form 4 filed by Rothe EricForm 4Grant or award
Compare Eric Rothe with
- Eric Rothe vs Snehal Patel1 shared
- Eric Rothe vs Jaye Thompson1 shared
- Eric Rothe vs David McWilliams1 shared
- Eric Rothe vs Frank Joseph Daugherty1 shared
- Eric Rothe vs Kenneth Hallock1 shared
Other insiders at the same companies
Questions about Eric Rothe
- What is Eric Rothe's role at Greenwich LifeSciences, Inc.?
- Eric Rothe reports to the SEC as director at Greenwich LifeSciences, Inc. (GLSI), according to the latest filing on December 27, 2024.
- Has Eric Rothe bought or sold stock recently?
- No open-market purchases or sales by Eric Rothe are on file. The filings report grant or award.
- How do I get alerts when Eric Rothe files?
- Follow Eric Rothe on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Eric Rothe (SEC CIK 0001806919). Totals count each trade once, skipping amendments whose original is on file, from Jun 24, 2022 on. View on SEC EDGAR · Get this as JSON